Synapse - Works

Results (1830)

Development of targeted ansamycins as novel anti-steroid agents and tyrosine kinase inhibitors in the treatment of breast and prostate cancers

Meeting Abstract

Zheng, F. F.; Kuduk, S. D.; Munster, P. N.; Chiosis, G.; Sepp-Lorenzino, L.; Danishefsky, S. J.; Rosen, N.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

A phase I/II trial of intraperitoneal (IP) cisplatin (CDDP) with IP gemcitabine (GEM) in patients (pts) with epithelial ovarian cancer

Meeting Abstract

Sabbatini, P.; Aghajanian, C.; Hensley, M.; Tong, W.; Soignet, S.; Hoskins, W.; O'Flaherty, C.; Pezzulli, S.; Barakat, R.; Spriggs, D.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

Clinical evaluation of the Bayer Immuno 1 HER-2/neu assay in healthy women and women with benign disease and breast cancer

Meeting Abstract

Goldblatt, J. L.; Neaman, I. E.; Hussain, M.; Cook, G. B.; Smith, C.; Schwartz, M. K.; Bruzek, D.; Chan, D. W.; Allard, W. J.
Clinical Chemistry (2000)

Fulltext@MSK | Save

Multicenter evaluation of the analytical and clinical performance of the Bayer Immuno 1 (TM) HER-2/neu Assay

Meeting Abstract

Neaman, I. E.; Goldblatt, J. L.; Cook, G. B.; Bruzek, D.; Smith, C.; Morris, D. L.; Schwartz, M. K.; Chan, D. W.; Allard, W. J.
Clinical Chemistry (2000)

Fulltext@MSK | Save

Ecteinascidin 743, a novel chemotherapeutic agent that targets transcriptional activation of a subset of genes, including MDR1

Meeting Abstract

Scotto, K. W.; Jin, S. K.; Gorfajn, B.; Hu, Z.; Shtil, A.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

Ecteinascidin 743 (ET-743) and doxorubicin produce synergistic cytotoxic effects in soft tissue sarcoma lines HT-1080 and HS-18

Meeting Abstract

Takahashi, N.; Li, W. W.; Faircloth, G.; Jimeno, J.; Bertino, J. R.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

In vitro safety toxicology of kahalalide F, a marine natural product with chemotherapeutic potential against selected solid tumors

Meeting Abstract

Luber-Narod, J.; Smith, B.; Grant, W.; Jimeno, J. M.; Lopez-Lazaro, L.; Scotto, K.; Shtil, A.; Faircloth, G. T.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

A novel cell cycle inhibitor (Ro 31-7453): A clinical and pharmacokinetic study in patients with solid tumors

Meeting Abstract

Soignet, S.; Bienvenu, B.; Pezzulli, S.; Ng, K.; Vongphrachanh, P.; Breimer, L.; Zhi, J. G.; Dhingra, K.; Huber, M. H.; Spriggs, D.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

Pharmacokinetics of arsenic trioxide (ATO) in patients with relapsed/refractory acute promyelocytic leukemia (APL)

Meeting Abstract

Soignet, S.; Bienvenu, B.; Warrell, R. P.; Ellisson, R.; Spriggs, D.; Brannan, M.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

Structural mechanism for the inhibition of Abelson tyrosine kinase by a small molecule inhibitor that is effective in the treatment of chronic myelogenous leukemia

Meeting Abstract

Schindler, T.; Vidal, E.; Bornmann, W. G.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J.
Clinical Cancer Research (2000)

Fulltext@MSK | Save